Home
Mutual FundsInvesco India Pharma And Healthcare Fund Direct Growth
I

Invesco India Pharma And Healthcare Fund Direct Growth

EquitySectoral / Thematic
0.00%profitReturns

as on 07 Sep 2026

Overview
Direct vs Regular
Returns Comparison
Historical Data
Holdings
Fund Details
AMC Details
FAQs
Bulb

Invesco India Pharma And Healthcare Fund Direct Growth is a Equity mutual fund scheme launched on undefined NA NA. Investors can begin their investment journey with a minimum SIP of ₹100 or a lumpsum investment of ₹1,000.

Direct vs Regular Returns

No data

Sorry, No Data Available at this Moment!

View All Schemesarrow

Returns vs Category

No data

Sorry, No Data Available at this Moment!

*The above returns are absolute

Returns Vs Nifty 50

Historical Returns

No data

Sorry, No Data Available at this Moment!

SIP Logo

Start SIP with as Low as ₹100.

Start SIP

Historical NAV

10 Days
1 Month
3 Months
6 Months
1 Year
3 Years
5 Years
No data

Sorry, No Data Available at this Moment!

Asset Allocation

AUM

₹ 0.00 Cr

Cash Holding

-

Equity

-

Cash

-

Debt

-

Other

-

Sector Holdings

No data

Sorry, No Data Available at this Moment!

Stock Holdings

No data

Sorry, No Data Available at this Moment!

Fund Comparison

Fund Details

52W High NAV

₹ NaN

Min. SIP Amount

₹ 100.00

Min. Lumpsum Amount

₹ 1,000.00

AUM (in Cr.)

₹ 0.00

Expense Ratio

0.00%

Lock-in Period

No Lock in Period

52W Low NAV

₹ NaN

Inception Date

NA

Fund Age

-

Benchmark

BSE Healthcare TRI

Scheme Type

Open Ended

Stamp Duty

0.005% (from July 1st 2020)

Exit Load

  • Exit load of 0.50%, if redeemed within 3 months.

Tax Implication

  • If you redeem within 1 year, STCG are taxed at 20%; If you redeem after 1 year, and returns exceed ₹1.25 Lakhs in a financial year, LTCG are taxed at 12.5%

Fund Managers

NameQualification
Aditya Khemani
Mr. Khemani has done B.Com (Hons) and PGDM from IIM, Lucknow.

Fund Objective

To generate long term capital appreciation by investing predominantly in equity and equity related securities of the companies in Pharmaceuticals, Healthcare and allied sectors. There is no assurance that the investment objective of the Scheme will be achieved.

Risk-O-Meter

Investors understand that their principal will be at

Very High Risk

Risk Scale

Low

Moderately Low

Moderate

Moderately High

High

Very High

AMC Information

Invesco Mutual Fund

No. of Schemes

40

Total AUM

₹ 1,59,216.33 Cr

Contact Details

globewww.invescomutualfund.com
phone022 - 67310000
twitter@invescoindia
address

2101-A, A Wing, 21st Floor, MarathonFuturex, N.M.Joshi Marg,Lower Parel, Mumbai 400 013.

View All Schemesarrow

Open NFOs

No Data

Sorry, No Data Available at this Moment!

View Allarrow

Explore Mutual Funds by Type

Equity Fund

Equity Funds

High Risk, High Returns

Debt Fund

Debt Funds

Better Than FD

Hybrid Fund

Hybrid Funds

Some Equity, Some Debt

ELSS Fund

ELSS Funds

Save Tax in Section 80C

Index Fund

Index Funds

Buy an Entire Index!

Fund of Funds

Fund of Funds

One Fund, Many Assets

Popular Funds

Popular Schemes

View All MF Schemesarrow

Mutual Fund Calculators

SIP Calculator

SIP Calculator

Lumpsum Calculator

Lumpsum Calculator

SIP Goal Calculator

SIP Goal Calculator

SWP Calculator

SWP Calculator

Yearly SIP Calculator

Yearly SIP Calculator

View Allarrow

FAQs

Invesco India Pharma And Healthcare Fund was launched on undefined NA NA.
The current NAV of Invesco India Pharma And Healthcare Fund is ₹10.0000 as of 07 Sep 2026.
The latest value of AUM of Invesco India Pharma And Healthcare Fund is ₹0.00 crores as of 07 Sep 2026.
The return on investment of Invesco India Pharma And Healthcare Fund is:
  • In the past 1Y: 0.00%
  • In the past 3Y: 0.00%
  • In the past 5Y: 0.00%
The expense ratio of Invesco India Pharma And Healthcare Fund is 0.00%.
The exit load of Invesco India Pharma And Healthcare Fund is as follows:
Exit load of 0.50%, if redeemed within 3 months.
The portfolio of Invesco India Pharma And Healthcare Fund includes:
No Data

No data to show right now!


Top 3 sectoral holdings include:
On the risk scale of Low, Moderately Low, Moderate, Moderately High, High and Very High, the risk-o-meter of Invesco India Pharma And Healthcare Fund is Very High.
The fund manager of Invesco India Pharma And Healthcare Fund is Aditya Khemani.
If you wish to invest in Invesco India Pharma And Healthcare Fund, the minimum SIP amount is ₹100 and Lumpsum is ₹1,000.
You can easily invest in mutual funds at 0% commission on Dhan. Here's how you can directly invest in Invesco India Pharma And Healthcare Fund:
  • Open Demat Account on Dhan if you don't have one.
  • Analyze the fund performance.
  • Invest via SIP or Lumpsum.
Candle bars with Screen

Invest in

Invesco India Pharma And Healthcare Fund

Pay 0% Commission!

Indian Flag

+91

Or Scan the QR Code to download the Dhan App

QR code Logo


Invest in Top Rated Funds at

0% Commission!

Choose from 1500+ Direct Mutual Funds.


border
logo

Join our Community

community logo

Follow us on

twitter
telegram
Linkedin
youtube
instagram
facebook

built with love
for Indians who love to invest & trade

raise

We are part of Raise Financial Services

raise
raise

Explore  |  Sitemap


*All securities mentioned on this website are exemplary and not recommendatory.

*Current prices on the website are delayed by 15 mins, login to check live prices.

We are bullish on India, we are bullish on India's prospects to be one of the largest economies in the world. We believe that the stock market provides a unique opportunity for all of India's traders and investors to participate in the growth story of the country.

Yet, most investing & trading platforms in India have remained more or less the same over the past decade. Times have changed and retail traders and investors have become smarter about managing their trades and money. Modern traders & investors require an online trading platform that helps them keep up with the technological advancements of our time.

That's why we're building Dhan - to help you trade, to help you invest, and to help you participate in India's growth stock via the stock market with awesome features and an incredible experience.

We are doing so by giving you access to not just one but 6 products within the Dhan ecosystem:


This means that with Dhan, you'll be able to start:


Lakhs of users already trust Dhan for their online stock trading and investing needs. Dhan is growing rapidly because of the love we receive from SuperTraders and Long-Term Investors who acknowledge that the platform is innovating for them, building super useful features that help them do everything from investing in stock market to trading F&O like a pro on the Tradingview charts and much more.

While we are growing, we will always remember why we started building in the first place - you. Our user-first approach will always be at the heart of our philosophy. Come join us on this incredible journey!

Try it out, you can close your account at anytime using this link.

©2021-2026 Raise Securities Private Limited (formerly Moneylicious Securities Private Limited). All rights reserved. CIN: U74999MH2012PTC433549 Raise Securities is part of Raise Financial Services and works closely with Raise Partners across services.

SEBI Stock Broker Registration No: INZ000006031 | Depository Participant (CDSL) ID: IN-DP-289-2016 | SEBI Research Analyst Registration No: INH000023357
Exchange Membership No. : NSE: 90133 | BSE: 6593 | MCX: 56320
Registered & Corporate Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai – 400104, Customer Care: 9987761000.

Details of client bank account

For any query / feedback / clarifications, email at help@dhan.co.

In case of grievances for any of the services rendered by Raise Securities Private Limited, please write to grievance@dhan.co (for NSE, BSE and MCX) or grievancedp@dhan.co (for Depository Participant). Please ensure that you carefully read the Risk Disclosure Document as prescribed by SEBI, our Terms of Use and Privacy Policy. Compliance Officer: Mr. Manish Garg and Mobile: 8655740961 Email: complianceofficer@dhan.co To lodge your complaints using SEBI SCORES, click here.


Disclaimer: All communications with the client via chat, phone, or email are for support purposes only. Any commitments or statements made by the agent (human or virtual) shall not be binding on the company.


DHAN is a brand owned by Raise Securities Private Limited. All DHAN clients are registered under Raise Securities Private Limited. Clients are advised to refer to our company as Raise Securities Private Limited when communicating with regulatory authorities.


Procedure to file a complaint on SEBI SCORES/SMART ODR Portal: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances. You may refer the website https://scores.sebi.gov.in/ for more information. You may also download the SEBI Scores app to log a complaint Android: https://play.google.com store apps sebiscores iOS: https://apps.apple.com app sebiscores.


Disclaimer: Investment in the securities market are subject to market risks, read all the related documents carefully before investing. Brokerage will not exceed the SEBI prescribed limit


Attention investors:

  1. Stock brokers can accept securities as margins from clients only by way of pledge in the depository system w.e.f September 01, 2020.
  2. Update your e-mail and phone number with your stock broker / depository participant and receive OTP directly from depository on your e-mail and/or mobile number to create pledge.
  3. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month.

Note: As a policy we do not give stock tips or recommendations and have not authorized anyone to give this on behalf of us. If you know anyone claiming to be a part of Dhan / / Raise or our associate companies or partners and offering such services, please report us on help@dhan.co. Important Information for Investors: To prevent unauthorized transactions in your trading / demat account, do not share your account details, credentials or any personal details with anyone. Keep your mobile number updated with your Stock Broker, Depository Participant and ensure that the same is registered with Stock Exchanges, Depository and KRAs. You will receive alerts and information on your registered mobile number / email for debit and other important transactions in your demat account directly from CDSL / Exchange on the same day. KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Stock Broker, DP, Mutual Fund, etc.), you need not undergo the same process again when you approach another intermediary. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. This is issued in the interest of investors.


Investors should be cautious on unsolicited emails and SMS advising to buy, sell or hold securities and trade only on the basis of informed decision. Investors are advised to invest after conducting appropriate analysis of respective companies and not to blindly follow unfounded rumours, tips etc. Further, you are also requested to share your knowledge or evidence of systemic wrongdoing, potential frauds or unethical behaviour through the anonymous portal facility provided on BSE & NSE website. Issued in the interest of the investors.


Raise Securities Private Limited also known as Dhan is only an order collection platform that collects orders on behalf of clients and places them on BSE StarMF for execution. Client expressly agrees that Dhan is not liable or responsible and does not represent or warrant any damages regarding non- execution of orders or any incorrect execution of orders with regard to the funds chosen by the client or due to, but not being limited to, any link/system failure, delay in transfer of the funds on account of any unforeseen circumstances/issues in the banking system/payment aggregators or any other problems that may result in a delay in crediting the funds into the BSE Star MF's bank account. Raise Securities Private Limited (Dhan) does not engage in proprietary trading on its own account.


Mutual fund investments are subject to market risks, read all scheme related documents carefully before investing. Dhan is not a distributor or agent of any mutual fund. Mutual Funds are not exchange-traded products. Any related disputes will not have access to the Exchange-investor redressal forum or arbitration mechanism. For other disclaimers please refer https://dhan.co/advertisement-disclaimer/


Download client registration documents (Rights & Obligations, Risk Disclosure Document, Do's & Don'ts) in vernacular language: BSE | NSE | MCX


Kindly, read the Advisory Guidelines of BSE | NSE | MCX for investors as prescribed by the exchange with reference to their circular dated 27th August, 2021 regarding investor awareness and safeguarding client's assets


Important Links: SEBI | BSE | NSE | MCX | CDSL | SCORES | ODR Portal | Investor Charter for Stock Brokers | Investor Charter for DP | Investor Charter for Research Analyst | UCC Advisory | e-Voting for Shareholders | NCL Client Collateral details | MCXCCL Client Collateral details

Important Information: Terms of Usage | Disclaimers | Privacy Policy | Grievances | Grievances RA | Risk Management Policy | Risk Disclosure | Advertisement Disclaimer | Referral Terms & Conditions | Saarthi 2.0 Mobile App for Investors | Master Circular for Online Dispute Resolution